MaxCyte
Cell & Gene Therapy · Bioprocessing

MaxCyte: Risk & public record

MaxCyte: 31 research papers in five years.

Data updated Nov 20, 2026 · Back to the company report

What the registers and the postings say about this employer.

Legal entity active
MAXCYTE, INC.
Not checked
Sanctions lists
OFAC SDN, EU consolidated · sanctionssearch.ofac.treas.gov ↗
No match
Phishing reports
OpenPhish, Phishing.Database · openphish.com ↗
None
Layoff notices
US WARN notices on file · dol.gov ↗
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Public record

MaxCyte: 31 research papers in five years.

Research outputpapers its people wrote, per OpenAlex
31papers in five years
2.2kcitations
CRISPR and Genetic Engineering
Biochemistry, Genetics and Molecular Biology
33 papers
CAR-T cell therapy research
Medicine
33 papers
Virus-based gene therapy research
Biochemistry, Genetics and Molecular Biology
30 papers
Immunotherapy and Immune Responses
Immunology and Microbiology
25 papers
RNA Interference and Gene Delivery
Biochemistry, Genetics and Molecular Biology
24 papers
Patents
Published US applications
8
Each line links its register: the agency's page, the EU Transparency Register, the FEC, the USPTO, CourtListener.